Cancel
Known information
- Received a bachelor's degree in biology and genetics from the University of British Columbia
- Earned a graduate degree in Cellular and Molecular Pathology from Vanderbilt University, specializing in neuropathology
- Formerly held the position of Vice President of Program Management at Puma Biotechnology
- Provided project management oversight to the recent NDA and MAA regulatory submissions at Puma Biotechnology
- Currently provides portfolio level oversight to development stage projects at Locus Biosciences
- Is the executive sponsor in charge of leading the build-out of Puma’s commercialization business systems infrastructure to support their first successful product launch
About Locus Biosciences
Locus Biosciences is a biotechnology company focused on developing precision medicines to combat antimicrobial resistance and treat microbiome-related diseases, utilizing CRISPR-engineered bacteriophage therapies and a robust biopharmaceutical development platform.
Report inaccurate information
